BioNTech AG announced additions to its corporate leadership. The company added Ryan Richardson as Senior Vice President Corporate Development and Strategy and Dr. Ulrich Wandschneider as member of the supervisory board. Prior to joining the company, Richardson was an Executive Director in the Global Healthcare Investment Banking team at J.P. Morgan in London. Before his recent appointment as member of BioNTech’s supervisory board, Wandschneider was Chairman of the supervisory board of Asklepios Kliniken GmbH & Co. KGaA.